Efficacy of Deucravacitinib over time in Psoriasis by Baseline Total Body Surface Area: Post Hoc Analysis of the Randomized, Double-blind, Placebo-controlled Phase 3b/4 PSORIATYK SCALP Trial. J of Skin [Internet]. 2025 Mar. 17 [cited 2025 May 20];9(2):s537. Available from: https://skin.dermsquared.com/skin/article/view/3314